Aenova has an excellent track record in developing and manufacturing drug products containing high potent APIs up to OEB 5.
We are partner of choice for novel/innovative product solutions as well as commercial high-volume manufacturing high-potent drug product manufacturing.
Aenova’s high potent API production solutions feature dedicated plants, applying high safety equipment and state of the art API risk management concepts that ensure full protection of product, patients and environment. All of our high-potent API plants have a comprehensive record of global GMP inspections.
Our full-service manufacturing and supply-chain services are integrated with our development / technical transfer / analytical services.
Our oncology drug product manufacturing includes virtually all solid dosage forms and all key manufacturing technologies variably arranged. Batch sizes range from 0.5-500 kg. We also offer customer-specific ‘plant-in-plant’ solutions.
For oncology products Aenova has an excellent track record and long-standing experience in development and production of novel/innovative drug products as well as generics.
Capacity: >1.5 billion
OEB level: 3-5
Bulk manufacturing solutions offer highly efficient closed-containment equipment trains. Packaging services include product-specific blister solutions, e.g. oral contraceptives. Our high-potent API plants have world-wide GMP approvals.
For low-dosed high potent APIs (hormones and hormone-like substances) Aenova has an excellent track record and long-standing experience in development and production of novel/innovative drug products as well as generics.
Capacity: >3 billion
OEB level: 3-5